OOIR: Observatory of International Research

Papers

(The TQCC of Tuberculosis is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Prevalence of BCG scar among vaccinated children and its correlation with Mantoux skin test at Omdawanban area, Sudan	59
Editorial Board	38
Lumbosacral tuberculosis, a rare manifestation of Pott's disease – How identified human skeletons from the pre-antibiotic era can be used as reference cases to establish a palaeopathological diagnosis	34
Hematological parameters in newly diagnosed TB patients: A systematic review and meta-analysis	22
Enhanced efficacy of BCG vaccine formulated in adjuvant is dependent on IL-17A expression	22
Editorial Board	21
More than one millennium (2nd-16th century CE) of the White Plague in the Carpathian Basin – New cases, expanding knowledge	21
Sensitive lipid biomarker detection for tuberculosis in late Neanderthal skeletons from Subalyuk Cave, Hungary	20
Editorial Board	19
Aims and Scope, Copyright, Publication information, Orders and Claims, Advertising information, Author inquiries, Permissions, Funding body, Permanence of paper, Impressum (German titles only) and GFA	19
Editorial Board	18
Domestic pigs experimentally infected with Mycobacterium bovis and Mycobacterium tuberculosis exhibit different disease outcomes	18
Performances of bioinformatics tools for the analysis of sequencing data of Mycobacterium tuberculosis complex strains	17
Franz Tappeiner (1816–1902) and his pioneering studies on tuberculosis	16
Immunoendocrine abnormalities in the female reproductive system, and lung steroidogenesis during experimental pulmonary tuberculosis	16
Biofilms in tuberculosis: What have we learnt in the past decade and what is still unexplored?	16
Expression of vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule (PECAM-1/CD31) in intestinal tuberculosis	15
Editorial Board	15
Drug resistant tuberculosis cases from the Copperbelt province and Northern regions of Zambia: Genetic diversity, demographic and clinical characteristics	14
Editorial Board	14
Editorial Board	14
Country-wide genotyping of Mycobacterium tuberculosis complex in Singapore, 2011–2017	13
A rare case of calvarial tuberculosis from the Avar Age (8th century CE) cemetery of Kaba–Bitózug (Hajdú-Bihar county, Hungary) – Pathogenesis and differential diagnostic aspects	13
Tuberculosis and autoimmunity: Common features	12
Efficacy of inhaled CPZEN-45 in treating tuberculosis in the guinea pig	12

Using genomic DNA copies to enumerate Mycobacterium tuberculosis load in macaque tissue samples	12
Deep whole-genome sequencing reveals no evidence for heteroresistance influencing treatment outcomes among drug-susceptible tuberculosis patients	12
Reduced macrophage killing of M. avium drives infection risk in post-menopausal patients	12
Knockout of MRA_1916 in Mycobacterium tuberculosis H37Ra affects its growth, biofilm formation, survival in macrophages and in mice	12
Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis	11
Potential biomarker enhancing the activity of tuberculosis, hsa-miR-346	11
Mycobacterial MCE proteins as transporters that control lipid homeostasis of the cell wall	11
Effective combined antiretroviral therapy provides partial immune recovery to mycobacterial antigens in vertically infected, BCG-vaccinated youth living with HIV	11
Identification of anti-lipoarabinomannan antibodies against mannan core and their effects on phagocytosis of mycobacteria by human neutrophils	11
Concentrated specimen smear microscopy utilising a polymer membrane sandwich filtration vessel for the detection of acid-fast bacilli in health facilities in Sabah, East Malaysia	10
Patterns of genomic interrelatedness of publicly available samples in the TB portals database	9
Colorado mycobacteria conference 2022: Focus on Nontuberculous mycobacteria	8
Dynamics of tuberculosis infection in various populations during the 19th and 20th century: The impact of conservative and pharmaceutical treatments	8
Upper Paleolithic tuberculosis: A probable case illustrated by paleoimaging methods (Azilian site of Les Iboussières, France)	8
Toxin-Antitoxin system of Mycobacterium tuberculosis: Roles beyond stress sensor and growth regulator	8
Plasma adipocytokines distinguish tuberculous lymphadenitis from pulmonary tuberculosis	8
Preclinical tests for salicylhydrazones derivatives to explore their potential for new antituberculosis agents	8
Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing	8
A novel chemogenomic discovery platform identifies bioactive hits with rapid bactericidal activity against Mycobacteroides Abscessus	8
Predictive biomarkers for latent Mycobacterium tuberculosis infection	8
Assessment of transcriptional markers for the differentiation of Mycobacterium mungi infection status in free-ranging banded mongoose (Mungos mungo)	7
The rv2820c K114N mutation is related with capreomycin tolerance	7
Combined cerebrospinal fluid metabolomic and cytokine profiling in tuberculosis meningitis reveals robust and prolonged changes in immunometabolic networks	7
Exhaled breath analysis: A promising triage test for tuberculosis in young children	7
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen	7
Differential diagnostic value of simultaneous detection of CD69 and HLA-DR on host T and NK cells in QFT-TB assay for identifying active tuberculosis	7
Mycobacterium bovis BCG dodecin gene codes a functional protein despite of a start codon mutation	7
Paleopathology and evolution of tuberculosis editorial	7
Mycobacterium bovis mutant in the virulence factors PhoP, ESAT-6 and CFP-10 persisted in mouse organs after a year post-vaccination	7
Integrative and comparative genomic analyses of mammalian macrophage responses to intracellular mycobacterial pathogens	7
Corrigendum to “Quantitative proteomics reveals plasma protein profile and potential pathways in pulmonary tuberculosis patients with and without diabetes” [Tuberculosis 143 (2023) 102424]	7
Steroid immune responsive gene regulation in Mycobacterium tuberculosis infection in vitro	7
Professor David Minnikin Memorial Lecture: An era of the mycobacterial cell wall lipid biomarkers	7
Detection of Mycobacterium tuberculosis transrenal DNA in urine samples among adults in Peru	7
Utility of the Whole Genome Sequencing based methodologies in routine European tuberculosis reference laboratory network setting	6
The first probable case with tuberculous meningitis from the Hun period of the Carpathian Basin – How diagnostics development can contribute to increase knowledge and understanding of the spatio-tempo	6
Tuberculosis before and after the Black Death (1346–1353 CE) in the Hospital of St John the Evangelist in Cambridge, England	6
The Rv3874-Rv3875 chimeric protein shows a promiscuous serodiagnostic potential for tuberculosis	6
Polyfluorinated salicylic acid analogs do not interfere with siderophore biosynthesis	6
A case of childhood tuberculosis from late mediaeval Somerset, England	6
Biomarkers to predict FDG PET/CT activity after the standard duration of treatment for spinal tuberculosis: An exploratory study	6
Pulmonary tuberculosis biomarker miR-215-5p inhibits autophagosome-lysosome fusion in macrophages	6
Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic	6
Limited sampling strategies for therapeutic drug monitoring of anti-tuberculosis medications: A systematic review of their feasibility and clinical utility	6
Increasing circulation of multi-drug resistant tuberculosis strains in Buryatia, high-burden and ethnically diverse region in the Russian Far East	6
Diagnostic value of lncRNAs LINC00152 and LARS2-AS1 and their regulatory roles in macrophage immune response in tuberculosis	6
Repression of BRD4 mitigates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium-infected macrophages by repressing endoplasmic reticulum stress	6
The paradoxes of Mycobacterium tuberculosis molecular evolution and consequences for the inference of tuberculosis emergence date	6
Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease	6
Immunomodulation by epigenome alterations in Mycobacterium tuberculosis infection	6

Escalate: Linezolid as an add on treatment in the intensive phase of tubercular meningitis. A randomized controlled pilot trial	6
The use of Mycobacterium tuberculosis H37Ra-infected immunocompetent mice as an in vivo model of persisters	6
Evaluation of the performances of InnowaveDx MTB-RIF assay in the diagnosis of pulmonary tuberculosis using bronchoalveolar lavage fluid	6
Editorial Board	6
Discovery and biological evaluation of an adamantyl-amide derivative with likely MmpL3 inhibitory activity	6
Bergenin potentiates BCG efficacy by enriching mycobacteria-specific adaptive memory responses via the Akt-Foxo-Stat4 axis	6
Editorial Board	5
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients	5
Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster	5
Spray dried tigecycline dry powder aerosols for the treatment of Nontuberculous mycobacterial pulmonary infections	5
Down-regulation of GAS5 has diagnostic value for tuberculosis and regulates the inflammatory response in mycobacterium tuberculosis infected THP-1 cells	5
Mycobacterium abscessus drug discovery using machine learning	5
Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis: A preliminary biomarker discovery study	5
Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis	5
Deferiprone-gallium-protoporphyrin (IX): A promising treatment modality against Mycobacterium abscessus	5
Improving host-directed therapy for tuberculous meningitis by linking clinical and multi-omics data	5
Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis	5
Characterization of embB mutations involved in ethambutol resistance in multi-drug resistant Mycobacterium tuberculosis isolates in Zambia	5
Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis	5
GlfT1 down-regulation affects Mycobacterium tuberculosis biofilm formation and its in-vitro and in-vivo survival	5
Genomic comparison of two strains of Mycobacterium avium subsp. paratuberculosis with contrasting pathogenic phenotype	4
Evaluating amikacin minimum inhibitory concentration in trailing growth for Mycobacterium avium complex	4
Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice	4
Quantitative proteomics reveals plasma protein profile and potential pathways in pulmonary tuberculosis patients with and without diabetes	4
Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis	4
Urine-based ELISA using a recombinant chimeric protein for the diagnosis of paucibacillary and multibacillary leprosy	4
Heterogeneous fitness landscape cues, pknG high expression, and phthiocerol dimycocerosate low production of Mycobacterium tuberculosis ATCC25618 rpoB S450L in enriched broth	4
Quinoline hybrid derivatives as effective structural motifs in the treatment of tuberculosis: Emphasis on structure-activity relationships	4
Isoniazid-induced pancreatitis: A systematic review	4
In vitro stimulation with nontuberculous mycobacteria induced a stronger cytokine response in leukocytes isolated from individuals with latent tuberculosis compared to those isolated from active tuber	4
Xpert MTB/RIF Ultra for the rapid diagnosis of extrapulmonary tuberculosis in a clinical setting of high tuberculosis prevalence country and interpretation of ‘trace’ results	4
Impaired control of Mycobacterium tuberculosis infection in mast cell-deficient KitW-sh/W−sh mice	4
Optimizing the formulation variables for encapsulation of linezolid into polycaprolactone inhalable microspheres using double emulsion solvent evaporation	4
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month	4
Blood levels of Mycobacterium tuberculosis (Mtb)antigen-triggered immune markers in people exposed to tuberculosis with regard to Mtb infection status and receipt of tuberculosis preventive therapy	4
Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex	4
Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01	4
Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus	4
Evaluation of tuberculosis diagnostic biomarkers in immunocompromised hosts based on cytokine levels in QuantiFERON-TB Gold Plus	4
Exploration of the diversity of multi-drug resistant Mycobacterium tuberculosis complex in Lagos, Nigeria using WGS: Distribution of lineages, drug resistance patterns and genetic mutations	4
Corrigendum to “Detecting clusters of high nontuberculous mycobacteria infection risk for persons with cystic fibrosis – An analysis of U.S. counties” [Tuberculosis 138 (2023) 102296]	4
Diagnosing osteoarticular tuberculosis and detecting rifampicin resistance: A comparative analysis of Truenat MTB Plus vs GeneXpert Ultra	4
mRNA profiling of cytokines to understand paradoxical response in HIV-uninfected tuberculous meningitis	4
Preclinical model of Mycobacteroides abscessus lung disease by nose-only exposure of mice to bacterial powder aerosol	4
The immunomodulatory effects of Mesenchymal stem cells on THP-1-derived macrophages against Mycobacterium tuberculosis H37Ra infection	4